Scientific Programme

Immune Modulation In CHB

Free Paper Session
Safety, PK, PD and Antiviral Activity of TLR7 Agonist RO7020531 in Patients with Chronic Hepatitis B Not Receiving Antiviral Treatment: a Phase 1 Study (TLR 7 program) – Dr. Filippo Canducci

1 June 2022
4.00pm – 4.15pm